Back to search

Cornell University

Targeting Triple-Negative Breast Cancer Metabolism Via Engineered Virus-Like Vesicle-Mediated Drug Delivery

Abstract

dc:description.abstract

Despite chemotherapy’s widespread application for cancer treatment, its targeted delivery to neoplastic tissue, especially those lipophilic in nature, remains a major challenge. Leukocyte-derived small extracellular vesicles (EVs) have emerged as promising drug carriers due to their intrinsic tumor-targeting abilities and immunological inertness. To enhance the stability and drug loading capabilities of EVs, we developed a virus-like vesicle (VLV) drug delivery system comprised of engineered leukocyte-derived EVs expressing activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) capsids and its 5’ untranslated region RNA stabilizing sequence. Our objective was to assess the VLV drug delivery platform for the encapsulation and delivery of hydrophobic mitochondrial-targeting chemotherapeutic drugs to treat triple-negative breast cancer (TNBC). Comparing endogenous and ex vivo loading strategies, endogenously loaded VLVs showed enhanced drug encapsulation and sustained cytotoxicity against TNBC cells over wild-type EVs. We conclude that the current system holds significant potential for the delivery of hydrophobic drugs to treat resistant cancers.

Degree

thesis:*
Name thesis:degree_name
M.S., Chemical Engineering
Level thesis:degree_level
Master of Science
Discipline thesis:degree_discipline
Chemical Engineering
Grantor
Cornell University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chong, Kellie
Chair dc:contributor.chair
  • Jiang, Shaoyi
Committee member dc:contributor.committeemember
  • Yu, Qiuming

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
17422661
Dc Identifier Other
ProQuest Submission ID: 12586
ProQuest Publication ID: 32171329

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Chong, Kellie. Targeting Triple-Negative Breast Cancer Metabolism Via Engineered Virus-Like Vesicle-Mediated Drug Delivery. Master of Science thesis, Cornell University, 2025. https://hdl.handle.net/1813/120719